TIP and PEMA join forces as PEMA is now part of the TIP Group
3.12.2019 10:00:00 EET | Business Wire | Press release
TIP Trailer Services, a portfolio company of I Squared Capital and one of the leading trailer leasing, rental, maintenance and repair providers across Europe and Canada, today announces it has completed the acquisition of PEMA GmbH, a commercial vehicle operational leasing and rental company offering services in Belgium, Czech Republic, Denmark, Germany, Poland, Sweden, and Switzerland. This follows the announcement of 26 July 2019 on the signing of the agreement with PEMA’s shareholder for the acquisition.
“This milestone solidifies TIP and PEMA’s strengths in transportation and logistics and positions our joint companies for long-term diversification and growth in keeping with our strategy,” said Bob Fast, President and CEO of TIP Trailer Services. “The combined business will leverage our strengthened geographical footprint, give us a more robust presence in Germany, power PEMA’s truck leasing and rental business, expand TIP’s European workshop network for all customers, and broaden our service offerings and client coverage network. This will benefit employees, customers, partners and shareholders alike.”
The combined companies have a longstanding experience in transportation and logistics across Europe and Canada, supporting customer needs throughout the entire lifecycle of trailers, trucks and swap bodies. Together they have approximately 90,000 trailers and trucks as well as over 100 workshops, offering one of the largest repair networks in Europe and Canada with 208 mobile service vans, providing a one-stop-shop solution for a wide variety of vehicle equipment. Customers will have a seamless service partner across Europe and Canada, simplifying their fleet management and enabling them to focus on their core business activities, while enjoying strong reliability and customer service.
The management of the combined companies are working together on an integration plan to allow a smooth transition. Until integration, existing contracts, services, terms and conditions and processes will remain in place at each of the businesses.
About TIP Trailer Services
TIP Trailer Services is an equipment service provider specializing in trailer leasing, rental, maintenance and repair, as well as other value-added services to transportation and logistics customers across Europe and Canada. The company has one of the largest and most diverse trailer rental and leasing fleets with over 70,000 units. Headquartered in Amsterdam, TIP has over 2,000 employees and services its customers from 98 locations in 17 countries across Europe and Canada.
About PEMA
Founded in 1976, PEMA is a commercial vehicle operational lease and rental company specializing in trucks and trailers and employs around 440 people. PEMA holds a diversified fleet of over 19,000 units with a wide selection of leading brands including Schmitz, Krone and Kögel (trailers) and DAF, Volvo, MAN, Mercedes-Benz and Renault (trucks). PEMA operates 18 locations throughout Northern and Central Europe including four in-house workshops.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191202005564/en/
Contact information
Contacts TIP Europe
Media
Marc Aandeweg
Vice President Sales & Marketing
T +31-(0)20-504-1767
M +31-(0)613-114293
E marc.aandeweg@tipeurope.com
Investor Relations
Kapil Sharma
Treasury and Investor Relations Director
T +31-(0)20-504-1677
M +31-(0)621-105358
E kapil.sharma@tipeurope.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom